featured article
NewNowNext
Read up on recent FDA hearings deciding the fate of type 2 diabetes drug Avandia... Click here to continue.
current issue - #24 - july 2010
wrap up
The proud winners of our recent Willie Mays giveaway recap their grand prize trip to San Francisco.
quotable quotes
Dr. Aaron Kowalski has encouraging words on the progress of the Artificial Pancreas, Dr. Steven Nissen comes out in favor of more stringent FDA guidelines, and Dr. Richard Bergenstal pushes for more focus on team-based diabetes care.
NewNowNext
A packed NewNowNext this issue! Read up on recent FDA hearings deciding the fate of type 2 diabetes drug Avandia and weight-loss drug Qnexa, Debiotech’s Android-compatible “JewelPUMP,” the OmniPod/DexCom integrated insulin pump/CGM, JDRF and sanofi-aventis’ partnership for cure-based research, OneTouch’s new (and thinner!) Delica Lancing System, JDRF’s newly-named CEO Jeffrey Brewer, and Diamyd’s “vaccine” for type 1 diabetes.
thinking like a pancreas
The last word on the ultimate challenge in blood sugar control from a real expert – Gary Scheiner discusses how to best balance exercise and sports in diabetes management.
learning curve
Welcome to the main event! We break down exciting findings from the largest diabetes meeting of the year, the American Diabetes Association’s annual Scientific Sessions – read on for more new therapies and new ways to use current therapies and diabetes technology.
diaTribe dialogue
Diabetes expert and former ADA President Dr. John Buse offers a take on the ADA and FDA and weighs in on the current regulatory environment and the impact of healthcare reform.
trial watch
Enrolling now are trials investigating the ability of weight-loss surgery to resolve type 2 diabetes, an Internet training program for teens with type 1 diabetes, and a couples-based intervention for type 2 diabetes.
sum musings
Kerri Morrone Sparling reviews the 2nd annual Roche Social Media Summit – and the real change put into action as a result of the first Summit.
